322 related articles for article (PubMed ID: 17187522)
1. Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.
Koon HB; Atkins MB
Expert Rev Anticancer Ther; 2007 Jan; 7(1):79-88. PubMed ID: 17187522
[TBL] [Abstract][Full Text] [Related]
2. Therapy for metastatic melanoma: an overview and update.
Boyle GM
Expert Rev Anticancer Ther; 2011 May; 11(5):725-37. PubMed ID: 21554048
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of advanced or metastatic melanoma.
Cebon J; Gedye C; John T; Davis ID
Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
[TBL] [Abstract][Full Text] [Related]
4. Melanoma treatment update.
Tsao H; Sober AJ
Dermatol Clin; 2005 Apr; 23(2):323-33. PubMed ID: 15837158
[TBL] [Abstract][Full Text] [Related]
5. Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations.
Kirkwood JM; Moschos S; Wang W
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2331s-2336s. PubMed ID: 16609054
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-based therapy and biochemotherapy for advanced melanoma.
Atkins MB
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2353s-2358s. PubMed ID: 16609058
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
Lorigan P; Eisen T; Hauschild A
Exp Dermatol; 2008 May; 17(5):383-94. PubMed ID: 18312390
[TBL] [Abstract][Full Text] [Related]
8. Treatment approaches for advanced cutaneous melanoma.
Stein JA; Brownell I
J Drugs Dermatol; 2008 Feb; 7(2):175-9. PubMed ID: 18335655
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies for melanoma.
Katipamula R; Markovic SN
Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
[TBL] [Abstract][Full Text] [Related]
10. Melanoma: from darkness to promise.
Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
[TBL] [Abstract][Full Text] [Related]
12. Melanoma and immunotherapy.
Eggermont AM; Schadendorf D
Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunotherapy in the treatment of melanoma.
Faries MB
Surg Oncol Clin N Am; 2006 Apr; 15(2):399-418. PubMed ID: 16632223
[TBL] [Abstract][Full Text] [Related]
14. Medical management of melanoma.
Brown CK; Kirkwood JM
Surg Clin North Am; 2003 Apr; 83(2):283-322, viii. PubMed ID: 12744611
[TBL] [Abstract][Full Text] [Related]
15. [Future of malignant stage I melanoma. Immunology and immunotherapy].
Nicolas JF; Berthier O; Trillet-Lenoir V; Claudy A; Revillard JP
Ann Dermatol Venereol; 1995; 122(5):324-35. PubMed ID: 8572476
[No Abstract] [Full Text] [Related]
16. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
Garbe C; Eigentler TK
Melanoma Res; 2007 Apr; 17(2):117-27. PubMed ID: 17496787
[TBL] [Abstract][Full Text] [Related]
18. Melanoma.
Benson C; Gore ME
Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
[No Abstract] [Full Text] [Related]
19. Current immunotherapy for melanoma.
Newton Bishop JA
Cancer Surv; 1996; 26():321-33. PubMed ID: 8783581
[No Abstract] [Full Text] [Related]
20. Metastatic melanoma in the older patient: special considerations.
Hegde UP; Grant-Kels JM
Clin Dermatol; 2013; 31(3):311-6. PubMed ID: 23608450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
